Effects of Selected Flavonoids and Caffeic Acid Derivatives on Hypoxanthine-Xanthine Oxidase-Induced Toxicity in Cultivated Human Cells

Abstract

Tissue damage as a result of oxygen radical generation may be involved in the pathogenesis of different diseases, carcinogenesis, aging and cell death. The inhibition of the proliferation rate of the immortalised human cell line ECV 304 after oxidant damage by oxygen radicals generated in a hypoxanthine-xanthine oxidase system and the protection provided by some selected flavone and flavonol glycosides as well as by caffeic acid and its derivatives was determined. The cytotoxicity of the reactive oxygen species was differentially influenced by selected flavonoids and seems to be determined by the pattern of substitution and by their lipophilicity. Apigenin and quercetin demonstrated the strongest effect on the inhibition of hypoxanthine-xanthine oxidase-induced toxicity (50 % restitution of the cells at a concentration of 0.36 μM and 3.1 μM, respectively). The beneficial effect of the flavonol glycosides rutin and hyperoside was weak, whereas flavone glycosides such as diosmin showed a better effect of protection.

Key words

ECV 304-cells - Hypoxanthine - xanthine oxidase - radical scavenger activity - flavonols - flavones - caffeic acid derivatives

References

• 1 Halliwell B, Gutteridge J MC. Free Radicals in Biology and Medicine. 2nd Edition Oxford; Clarendon Press 1989
• 2 Miller A L. Antioxidant Flavonoids: Structure, function and clinical use.  Alt Med Rev. 1996;  1 103-11
• 3 Pietta P G. Flavonoids as antioxidants.  J Nat Prod. 2000;  63 1035-42
• 4 Watzl B, Rechkemmer G. Flavonoide.  Ernährungs-Umschau. 2001;  48 498-502
• 5 Narayana K R, Reddy M S, Chaluvadi M R, Krishna D R. Bioflavonoids classification, pharmacological, biochemical effects and therapeutical potential.  Ind J Pharmacol. 2001;  33 2-16
• 6 Hertog M GL, Hollmann P CH. Potential health effects of the dietary flavonol quercetin.  European J Clin Nutr. 1996;  50 63-71
• 7 Knekt P, Järvinen R, Reunanen A. Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study.  BMJ. 199;  312 487-91
• 8 Gräfe E U. Relative systemische Verfügbarkeit und Pharmakokinetik von Quercetin und Quercetinglycosiden (Quercetin-4′-O-glucosid und Quercetin-3-O-rutinosid) im Menschen. Ph. D. Thesis, University of Würzburg 2001
• 9 Lamson D W, Brignall M S. Antioxidants and cancer III: Quercetin.  Alt Med Rev. 2000;  5 96-208
• 10 Metz G. Flavonoide Teil III: Trotz Resorptionsschwächen gut wirksam.  Pharm Ztg. 2000;  145 2206-08
• 11 Cos P, Li Y, Calomme M, Hu J P, Cimanga K, Van Poel B. et al . Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.  J Nat Prod. 1998;  61 71-6
• 12 Sugihara N, Ohnishi M, Imamura M, Furuno K. Differences in antioxidative efficiency of catechins in various metal-induced lipid peroxidations in cultures hepatocytes.  J Health Sci. 2001;  47 99-106
• 13 Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F. Flavonoids as antioxidant agents: Importance of their interaction with biomembranes.  Free Rad Biol Med. 1995;  19 481-86
• 14 Merfort I, Heilmann J, Weiss M, Pietta P, Gardana C. Radical scavenger activity of three flavonoid metabolites studied by inhibition of chemoluminescence in human PMNs.  Planta Med. 1996;  62 289-92
• 15 Benoit J N, Taylor M S. Vascular reactivity following ischemia/reperfusion.  Front Biosci. 1997;  2 e28-33
• 16 Mossmann T. Rapid colorimetric assay of cellular growth and survival: application to proliferation and cytotoxicity assays.  J Immunol Methods. 1983;  65 55-63
• 17 Melzig M F, Löser B, Ciesielski S. Inhibition of neutrophil elastase activity by phenolic compounds from plants.  Pharmazie. 2001;  56 967-70